Norswertianolin Promotes Cystathionine γ-Lyase Activity and Attenuates Renal Ischemia/Reperfusion Injury and Hypertension.
Norswertianolin Promotes Cystathionine γ-Lyase Activity and Attenuates Renal Ischemia/Reperfusion Injury and Hypertension.
复制标题
Norswertianolin 促进胱硫醚γ-裂解酶活性并减轻肾缺血/再灌注损伤和高血压
DOI:
10.3389/fphar.2021.677212
复制
发表时间:
2021
影响因子:
5.6
通讯作者:
Geng B
中科院分区:
文献类型:
--
作者:
Niu Y;Du C;Cui C;Zhang H;Deng Y;Cai J;Chen Z;Geng B
Cystathionine gamma-lyase (CSE)/hydrogen sulfide (H2S) plays a protective role in cardiovascular diseases including hypertension and ischemia/reperfusion (I/R) injury. This study was aimed to screen natural small molecule compounds that activate CSE activity and then evaluate its effect(s) on kidney I/R injury and hypertension. Applying computer molecular docking technology, we screened the natural small molecule compound norswertianolin (NW)-specific binding to CSE. Using the microscale thermophoresis technology, we confirmed that the Leu68 site was the essential hydrogen bond site of NW binding to CSE. NW supplementation significantly increased CSE expression and its activity for H2S generation both in vivo and in vitro. In the model of acute and long-term kidney I/R injury, NW pretreatment dramatically attenuated kidney damage, associated with decreasing blood urea nitrogen (BUN), serum creatinine (Cr) level, reactive oxygen species (ROS) production, and cleaved caspase 3 expression. In spontaneously hypertensive rats (SHRs), NW treatment also lowered blood pressure, the media/lumen ratio of the femoral artery, and the mRNA level of inflammatory cytokines. In conclusion, NW acts as a novel small molecular chemical compound CSE agonist, directly binding to CSE, heightening CSE generation–H2S activity, and then alleviating kidney I/R injury and hypertension. NW has a potential therapeutic merit for cardiovascular diseases.
登录
查看更多内容
影响因子:
--
作者:
Li, Na;Wang, Ming-Jie;Zhu, Yi-Chun
通讯作者:
Zhu, Yi-Chun
影响因子:
3
作者:
Ahmad, Fiaz Ud Din;Sattar, Munavvar Abdul;Johns, Edward James
通讯作者:
Johns, Edward James
DOI:
10.1161/atvbaha.118.311229
发表时间:
2018-09
期刊:
Arteriosclerosis, thrombosis, and vascular biology
影响因子:
--
作者:
Brown IAM;Diederich L;Good ME;DeLalio LJ;Murphy SA;Cortese-Krott MM;Hall JL;Le TH;Isakson BE
通讯作者:
Isakson BE
影响因子:
2.1
作者:
Azizi, F.;Seifi, B.;Ahghari, P.
通讯作者:
Ahghari, P.
影响因子:
13.6
作者:
Bos, Eelke M.;Leuvenink, Henri G. D.;van Goor, Harry
通讯作者:
van Goor, Harry